GRVI News and Press, Grove Inc. From 07/14/22

HENDERSON, NV - ( NewMediaWire ) - July 14, 2022 - Grove Inc. (GRVI) Grove, Inc. has taken the formal steps to change its name to Upexi, Inc. and incorporated wholly owned subsidiaries; Upexi Holdings, LLC and Upexi Enterprises, LLC. The change is representative of the evolution of the busin...

Grove ( NASDAQ: GRVI ) CEO Allan Marshall provides corporate update and mentions that the company hit both our projected growth and profitability targets while remaining cash flow positive. Sales rose by an estimated 100% over 2021 with a compounded two-year sale...

HENDERSON, NV, July 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Grove, Inc.,  (NASDAQ:GRVI)  ("Grove" or the "Company"), today released a letter to shareholders from Chief Executive Officer, Allan Marshall. 2022 in review In our first year of operation as a ...

HENDERSON, NV - ( NewMediaWire ) - July 07, 2022 - Grove Inc. (GRVI) announced that its wholly owned Adtech platform, Interactive Offers, continues its expansion into eCommerce with the addition of new partners within the financial industry to further boost its growing list of advertisers an...

HENDERSON, NV - ( NewMediaWire ) - July 01, 2022 - Grove, Inc. (NASDAQ:GRVI) ("Grove" or the "Company"), today announced that it has completed a strategic debt investment to fund future growth. Under the terms of the loan, the Company, at the initial closing, drew $7.5 million of the $1...

HENDERSON, NV - ( NewMediaWire ) - May 26, 2022 - Grove Inc. (GRVI) expands into the rapidly growing market for medicinal mushrooms and superfoods with their newest product line,  Cure Mushrooms.   The brand offers a US-based product line of mushroom extracts. With cultiv...

HENDERSON, NV - ( NewMediaWire ) - May 18, 2022 - Grove Inc. (GRVI) SaaS Ad Tech Division, Interactive Offers issued a patent for a proprietary Ç that provides complete transparency for advertisers and publishers. Digital advertising has skyrocketed over the past couple years. " Th...

Gainers: Harpoon Therapeutics (HARP) +18%. Grove (GRVI) +11%. NanoViricides NNVC +11%. Travere Therapeutics TVTX +9%. Compass Therapeutics (CMPX) +4%. Losers: Chimerix CMRX -58%. Eliem Therapeutics ELYM -29%. Humacyte (HUMA) -20%. Va...

Grove press release (NASDAQ:GRVI): Q3 GAAP EPS of $0.03. Revenue of $29.3M (+118.7% Y/Y). Shares +11.8%. For further details see: Grove GAAP EPS of $0.03, revenue of $29.3M

$10.9 Million in Revenue, a 119% Increase Over Prior Year $4.3 Million Adjusted EBITDA Year to Date and Fourth Quarter Revenue Estimated at a Range of $16-18 Million HENDERSON, NV, May 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Grove, Inc. (NASDAQ:GRVI) ...